ClinConnect ClinConnect Logo
Search / Trial NCT05501990

Study on the Accessibility and Feasibility of Intelligent Applet for Health Intervention of Cancer Patients

Launched by RUIJIN HOSPITAL · Aug 12, 2022

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new app designed to help manage the health of cancer patients before and after surgery. The app aims to make communication between patients and doctors easier and more effective, especially in the fast-paced digital world we live in today. By improving how cancer care is delivered through technology, the researchers hope to enhance patient outcomes and overall health management.

To participate in this trial, you need to be a cancer patient who can use a smartphone and access the internet. You should also be able to understand and follow the instructions provided during the study. If you have a serious medical condition, such as a heart device, you may not be eligible. Participants can expect to engage with the app throughout their treatment, helping to improve their care experience. This trial is currently recruiting participants of all genders, typically aged 65 and older, who are willing to contribute to this important research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Sign and date informed consent;
  • Commit to abide by the research procedures and cooperate with the implementation of the whole research process ;
  • Can adhere to and cooperate with research intervention;
  • Tumor patients;
  • Patients/family members can use smart phones to access the Internet;
  • Patients/family members have sufficient cognitive and reading ability;
  • No mental illness;
  • No serious visual impairment
  • Exclusion Criteria:
  • Equipped with specific devices (such as cardiac pacemaker);
  • Those who do not meet the conditions listed in the inclusion criteria.

About Ruijin Hospital

Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, is a leading medical institution in China recognized for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, Ruijin Hospital integrates cutting-edge medical practices with rigorous scientific investigation. The hospital's multidisciplinary teams are dedicated to developing new therapeutic approaches, improving patient outcomes, and contributing to global medical knowledge. As a sponsor of clinical trials, Ruijin Hospital ensures adherence to the highest ethical standards and regulatory compliance, fostering an environment of collaboration and excellence in clinical research.

Locations

Shanghai, , China

Patients applied

0 patients applied

Trial Officials

Lei Huang, PhD, MD

Principal Investigator

Ruijin Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials